Olfactory Dysfunction of Rhinosinusitis - Cyclic Adenosine Monophosphate (cAMP)/Calcium Signaling Study
cAMP
1 other identifier
observational
99
1 country
1
Brief Summary
The study examines the biochemistry underlying human olfaction in both normal and diseased states. The study aims are: 1. to determine the levels of cAMP in olfactory tissue from people with chronic rhinosinusitis and other nasal disorders. 2. to correlate preoperative olfactory function with cAMP levels from biopsied olfactory tissue. 3. to determine odorant and pheromone-mediated activation of cultured human olfactory sensory neurons using calcium imaging and 4. to determine odorant and pheromone-mediated activation of cultured human olfactory sensory neurons using "smell-chip" technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 31, 2009
CompletedFirst Posted
Study publicly available on registry
September 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedDecember 11, 2014
December 1, 2014
4.7 years
August 31, 2009
December 10, 2014
Conditions
Keywords
Eligibility Criteria
Patients presenting to the University of Washington Rhinology Clinic for evaluation of sinus problems
You may qualify if:
- Subjects will be 18 years old and over and scheduled for one of the following:
- endoscopic sinus surgery for chronic sinusitis
- endoscopic transnasal approach to the pituitary for pituitary tumor removal
- endoscopic inferior turbinectomy or septoplasty for nasal congestion
- endoscopic repair of cerebrospinal fluid (CSF) leaks
You may not qualify if:
- Subjects are excluded if they are unable to give informed consent or unable to complete self-administered questionnaires due to English language barrier, cognitive impairment, or severe medical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Greg Davislead
Study Sites (1)
University of Washington Medical Center
Seattle, Washington, 98195, United States
Biospecimen
Samples consist of discarded tissue resulting from the following clinical procedures: endoscopic sinus surgery for chronic sinusitis, endoscopic transnasal approach to the pituitary for pituitary tumor removal, endoscopic inferior turbinectomy or septoplasty for nasal congestion and endoscopic repair of CSF leaks. Samples will only be retained for 1 year post-surgery and then destroyed.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Greg E Davis, MD, MPH
University of Washington
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 31, 2009
First Posted
September 2, 2009
Study Start
August 1, 2009
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
December 11, 2014
Record last verified: 2014-12